Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,048 mentions
- robotic manipulationmarket834 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology492 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology372 mentions
- vision-language-action modeltechnology355 mentions
- agentic AItechnology353 mentions
- Vision-Language Modeltechnology321 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Microsoftorganization291 mentions
- Googleorganization276 mentions
- NVIDIAorganization264 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology176 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology170 mentions
- IBMorganization163 mentions
Entity
Cullinan Therapeutics, Inc.
organization5 mentionslast seen Nov 9, 2026
A biopharmaceutical company developing potential first- or best-in-class, disease-modifying T cell engagers for autoimmune diseases and cancer.
Relationships 9
- Cullinan Therapeutics, Inc.employsMary Kay Fenton99% confidence5 sources
- Cullinan Therapeutics, Inc.developsCLN-04999% confidence2 sources
- Cullinan Therapeutics, Inc.developsvelinotamig99% confidence2 sources
- Cullinan Therapeutics, Inc.partners withTaiho Oncology, Inc.99% confidence2 sources
- Cullinan Therapeutics, Inc.employsJeffrey Jones99% confidence2 sources
- Cullinan Therapeutics, Inc.developszipalertinib99% confidence2 sources
- Cullinan Therapeutics, Inc.employsNadim Ahmed97% confidence1 source
- Cullinan Therapeutics, Inc.partners withTaiho Pharmaceutical Co., Ltd.95% confidence1 source
- Cullinan Therapeutics, Inc.developsCLN-97895% confidence1 source
Relationship
Cullinan Therapeutics, Inc.developsvelinotamig
99% confidence2 supporting mentions
Either name opens that entity’s relationships.
Sources 2
- filingSEC EDGARNov 9, 2026Cullinan Therapeutics, Inc. 8-K: Item 7.01: Regulation FD Disclosure; Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
Cullinan holds a global (ex-Greater China), all-indication, exclusive license to velinotamig from Genrix Bio
- filingSEC EDGARNov 4, 2026Cullinan Therapeutics, Inc. 8-K: Item 7.01: Regulation FD Disclosure; Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
Cullinan is evaluating subcutaneously administered velinotamig in a global Phase 1b/2a study